DOCQLAX- senna and docusate sodium tablet, film coated 
Par Pharmaceutical

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

DocQLax Tablets

Active ingredients (in each tablet)

Docusate sodium, 50 mg
Sennosides, 8.6 mg

Purpose

Stool Softener
Stimulant laxative

Uses

  • relieves occasional constipation (irregularity)
  • generally produces bowel movement in 6 to 12 hours

Warnings

Do not use

  • laxative products for longer than 1 week unless told to do so by a doctor
  • if you are presently taking mineral oil, unless told to do so by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that lasts over 2 weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • doses may be taken as a single dose or in divided doses preferably in the evening

adults and children 12 years and over

take 2 - 4 tablets daily
children 6 to under 12 years of agetake 1 - 2 tablets daily
children 2 to under 6 years of agetake up to 1 tablet daily
children under 2 years of ageask a doctor

Other information

  • each tablet contains: calcium 30 mg, sodium 3 mg VERY LOW SODIUM
  • do not use if imprinted safety seal under cap is missing or damaged.
  • store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F).
  • keep tightly closed.

You may report serious side effects to: 130 Vintage Drive, Huntsville, AL 35811.

Inactive ingredients

colloidal silicon dioxide, dicalcium phosphate, ethanol, FD&C blue #2, FD&C red #40, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil, polyethylene glycol, pregelatinized starch, silicon dioxide, sodium benzoate, stearic acid, titanium dioxide.

Mfg. for:
Qualitest Pharmaceuticals
Huntsville, AL 35811

REV. 01/10

PRINCIPAL DISPLAY PANEL

DocQLax Tablets 100ct label
DOCQLAX 
senna and docusate sodium tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0603-0149
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP)  
ALCOHOL (UNII: 3K9958V90M)  
FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
HYPROMELLOSE 2208 (100 MPA.S) (UNII: B1QE5P712K)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
MINERAL OIL (UNII: T5L8T28FGP)  
POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)  
STARCH, CORN (UNII: O8232NY3SJ)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
ColorREDScoreno score
ShapeROUNDSize10mm
FlavorImprint Code S134
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0603-0149-21100 in 1 BOTTLE; Type 0: Not a Combination Product07/26/200705/31/2020
2NDC:0603-0149-321000 in 1 BOTTLE; Type 0: Not a Combination Product07/26/200702/28/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart33407/26/200705/31/2020
Labeler - Par Pharmaceutical (011103059)
Registrant - Sunrise Pharmaceutical Inc (168522378)
Establishment
NameAddressID/FEIBusiness Operations
Sunrise Pharmaceutical Inc.168522378MANUFACTURE(0603-0149)

Revised: 9/2014
 
Par Pharmaceutical